Utilization of Nanoparticle Technology in Rheumatoid Arthritis Treatment Publisher Pubmed



Dolati S^{1, 2} ; Sadreddini S^{3, 4} ; Rostamzadeh D^{1, 2} ; Ahmadi M^{1, 2} ; Jadidiniaragh F⁵ ; Yousefi M^{3, 4} Show Affiliations
Source: Biomedicine and Pharmacotherapy Published:2016

Abstract

Rheumatoid arthritis (RA) is one of the common and severe autoimmune diseases related to joints. This chronic autoimmune inflammatory disease, leads to functional limitation and reduced quality of life, since as there is bone and cartilage destruction, joint swelling and pain. Current advances and new treatment approaches have considerably postponed disease progression and improved the quality of life for many patients. In spite of major advances in therapeutic options, restrictions on the routes of administration and the necessity for frequent and long-term dosing often result in systemic adverse effects and patient non-compliance. Unlike usual drugs, nanoparticle systems are planned to deliver therapeutic agents especially to inflamed synovium, so avoiding systemic and unpleasant effects. The present review discusses about some of the most successful drugs in RA therapy and their side effects and also focuses on key design parameters of RA-targeted nanotechnology-based strategies for improving RA therapies. © 2016 Elsevier Masson SAS.